Invenomic Capital Management LP Raises Stake in Herbalife Ltd $HLF

Invenomic Capital Management LP raised its position in Herbalife Ltd (NYSE:HLF) by 82.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 768,031 shares of the company’s stock after acquiring an additional 347,401 shares during the quarter. Invenomic Capital Management LP’s holdings in Herbalife were worth $9,900,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd acquired a new stake in Herbalife during the fourth quarter worth approximately $32,000. Aster Capital Management DIFC Ltd acquired a new position in shares of Herbalife in the 3rd quarter valued at $35,000. EverSource Wealth Advisors LLC increased its holdings in shares of Herbalife by 512.7% in the 4th quarter. EverSource Wealth Advisors LLC now owns 6,544 shares of the company’s stock valued at $84,000 after acquiring an additional 5,476 shares during the period. Advisory Services Network LLC acquired a new position in shares of Herbalife in the 3rd quarter valued at $65,000. Finally, New York State Teachers Retirement System acquired a new position in shares of Herbalife in the 4th quarter valued at $119,000.

Insiders Place Their Bets

In related news, COO Troy Hicks sold 38,377 shares of Herbalife stock in a transaction on Monday, May 18th. The shares were sold at an average price of $12.93, for a total value of $496,214.61. Following the transaction, the chief operating officer directly owned 9,062 shares in the company, valued at $117,171.66. This trade represents a 80.90% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Frank Lamberti sold 134,982 shares of Herbalife stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $13.50, for a total transaction of $1,822,257.00. Following the completion of the transaction, the insider owned 36,624 shares in the company, valued at approximately $494,424. This trade represents a 78.66% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 191,296 shares of company stock worth $2,551,678. 5.13% of the stock is currently owned by insiders.

Herbalife Price Performance

NYSE:HLF opened at $11.65 on Thursday. The firm’s fifty day moving average price is $13.86 and its 200 day moving average price is $14.87. Herbalife Ltd has a 1-year low of $7.56 and a 1-year high of $20.40. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of 5.11, a price-to-earnings-growth ratio of 0.70 and a beta of 0.88.

Herbalife (NYSE:HLF) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.61 by $0.03. Herbalife had a net margin of 4.67% and a negative return on equity of 41.47%. The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.30 billion. During the same period last year, the firm posted $0.59 EPS. Herbalife’s quarterly revenue was up 7.8% on a year-over-year basis. As a group, analysts expect that Herbalife Ltd will post 2.47 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on HLF shares. Mizuho set a $17.00 target price on shares of Herbalife in a report on Monday, May 4th. Wall Street Zen raised shares of Herbalife from a “buy” rating to a “strong-buy” rating in a report on Saturday, April 18th. Weiss Ratings raised shares of Herbalife from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday. Citigroup reaffirmed a “buy” rating and issued a $21.00 target price (up from $17.00) on shares of Herbalife in a report on Thursday, February 19th. Finally, Zacks Research cut shares of Herbalife from a “strong-buy” rating to a “hold” rating in a report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Herbalife has a consensus rating of “Hold” and a consensus target price of $17.80.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.